Back to Search Start Over

1,2,4-Thiadiazolidin-3,5-diones as novel hydrogen sulfide donors.

Authors :
Severino, Beatrice
Corvino, Angela
Fiorino, Ferdinando
Luciano, Paolo
Frecentese, Francesco
Magli, Elisa
Saccone, Irene
Di Vaio, Paola
Cirino, Giuseppe
Vellecco, Valentina
Bucci, Mariarosaria
Perissutti, Elisa
Santagada, Vincenzo
Caliendo, Giuseppe
Citi, Valentina
Calderone, Vincenzo
Servillo, Luigi
Casale, Rosario
Source :
European Journal of Medicinal Chemistry. Jan2018, Vol. 143, p1677-1686. 10p.
Publication Year :
2018

Abstract

Hydrogen sulfide (H 2 S) is an endogenous modulator that plays significant physio-pathological roles in several biological systems. In this research field there is a large interest in developing selective CBS and CSE inhibitors and H 2 S releasing moieties, that could be either used as therapeutic agents or linked to known drugs. One of the major problem is the limited availability of chemicals that ensure a controlled release of H 2 S in vitro as well in vivo. Aiming to obtain novel H 2 S donors, whose release properties could be appropriately modulated, we have synthesized a series of 1,2,4-thiadiazolidine-3,5-diones ( THIA 1–10 ) as innovative donors that could release H 2 S in controlled manner. All the synthesized compounds were evaluated for their H 2 S releasing properties by an amperometric approach and for their vasorelaxant ability on aorta rings. In order to rationalize the obtained results, a detailed study on the release mechanism has been performed using the most efficient H 2 S donor, THIA 3 (C max 65.4 μM and EC 50 1.7 μM). [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
02235234
Volume :
143
Database :
Academic Search Index
Journal :
European Journal of Medicinal Chemistry
Publication Type :
Academic Journal
Accession number :
126806372
Full Text :
https://doi.org/10.1016/j.ejmech.2017.10.068